Medius Associates
Medius provides an unrivalled range of specialised business development training solutions to cater for all levels of learning. This range extends from client specific in house tutorials through open enrolment courses to the Pharmaceutical Licensing Group’s distance learning modular MSc course.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Amiculum
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Company Details
Latest Content from PMHub
Rare disease market access – Launching orphan drugs in secondary markets: the Nordic and MENA regions
Press Releases | February 14, 2024 | Petauri Evidence
Join us live at 1.00pm (GMT)/2.00pm (CET)/8.00am (EST) on Thursday 29th February, to explore rare disease market access challenges and learn more about these high potential markets.
The pitfalls of cutting costs on systematic literature reviews: 11 common issues to avoid
White Papers and Resources | February 14, 2024 | Petauri Evidence
Embarking on a systematic literature review is a critical step in evidence synthesis, providing a foundation for robust decision-making in the healthcare landscape. As with most things, there are ways...
Product launch: What market research when?
White Papers and Resources | February 14, 2024 | Inizio
Get the insights you need, when you need them, for your product launch planning
Clinical trial considerations: Why digital matters…
White Papers and Resources | February 14, 2024 | Cuttsy + Cuttsy
Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.
Top-5 Trends in Virtual KOL Engagement
Press Releases | February 12, 2024 | Impetus Digital
Register now for one of our upcoming webinars (February 26-28)
Therapy Watch launches new tracker covering Alzheimer’s Disease
White Papers and Resources | February 12, 2024 | Inizio
The new Therapy Watch Alzheimer’s Disease tracker has recently launched in Germany, Japan and the US, with planned expansion into the remaining key European markets throughout 2024.
Medscape Education Leads the Industry into New Era of Precision Education with Guaranteed Impact
Press Releases | February 9, 2024 | Medscape Education
NEWARK, N.J., Feb. 8, 2024 /PRNewswire/ -- Medscape Education has just unveiled its pioneering approach to developing and delivering medical education designed to drive guaranteed reach, precision targeting, and impact during this...
Imagine More for the reporting of consensus programme outputs
Press Releases | February 9, 2024 | Resonant Group
The Bedrock team reflects on the latest published guidance in the development of consensus programmes
Therapy Watch launches new tracker covering pulmonary arterial hypertension (PAH)
White Papers and Resources | February 9, 2024 | Inizio
Therapy Watch Pulmonary Arterial Hypertension (PAH) is launching in the US market, with expansion into other geographies including Europe in 2024.
Hitting Every Beat—The Power of Education in Heart Failure
Press Releases | February 8, 2024 | Medscape Education
Heart failure can be a challenge to manage both for clinicians and patients. It’s a complex condition with various manifestations and presentations, and different disease stages that require different approaches...